Wentao Wu
Directeur des opérations chez Xynomic Pharmaceuticals, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Yinglin Mark Xu | M | - |
Xynomic Pharmaceuticals, Inc.
 Xynomic Pharmaceuticals, Inc. BiotechnologyHealth Technology Xynomic Pharmaceuticals, Inc. operates as biopharmaceutical company. It develops and commercializes innovative oncology drugs to address unmet medical needs in solid tumor and hematological malignancies and to improve cancer patients’ life expectancy and treatment prognosis. The company was founded by Yinglin Mark Xu in 2016 and is headquartered in Dover, DE. | 8 ans |
| Jia Yuan Tong | M | 49 |
Xynomic Pharmaceuticals, Inc.
Xynomic Pharmaceuticals, Inc. BiotechnologyHealth Technology Xynomic Pharmaceuticals, Inc. operates as biopharmaceutical company. It develops and commercializes innovative oncology drugs to address unmet medical needs in solid tumor and hematological malignancies and to improve cancer patients’ life expectancy and treatment prognosis. The company was founded by Yinglin Mark Xu in 2016 and is headquartered in Dover, DE. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Xian Min Wang | M | 81 | - | |
| Bai Qing Zhang | M | 71 | - | |
| Eileen Bridget Brody | F | 62 | - | |
| Cosimo J. Patti | M | 73 | 10 ans | |
| Lawrence S. Wizel | M | 81 | 6 ans | |
| Ying Du | M | 59 |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | - |
| Yang Yang | M | 56 | 3 ans | |
| Yan Gao | M | 51 | - | |
| Jinli Tang | F | - | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 10 | 90,91% |
| Chine | 1 | 9,09% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
